日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genome-wide copy number profiling enhances risk stratification in multiple myeloma by shallow whole-genome sequencing

通过浅层全基因组测序进行全基因组拷贝数分析可增强多发性骨髓瘤的风险分层。

Fang, Baijun; Zhu, Zunmin; Chang, Yinyin; He, Xiangxiang; Li, Shiyong; Li, Manqian; Yan, Susu; Zhu, Dandan; Li, Zhenling; Mao, Mao

Clinical characterization and targeted genetic mutation profiling of autoimmune disease-associated B-cell lymphoma

自身免疫性疾病相关B细胞淋巴瘤的临床特征及靶向基因突变谱分析

Di, Hongchen; Wang, Zixin; Ma, Rongjun; Yuan, Xiaoli; Jiang, Li; Zhou, Pan; Wang, Lifu; Zhu, Zunmin

Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma

zevorcabtagene autoleucel(一种全人源BCMA靶向CAR-T细胞疗法)治疗复发/难治性多发性骨髓瘤患者的II期研究

Chen, Wenming; Fu, Chengcheng; Fang, Baijun; Liang, Aibin; Xia, Zhongjun; He, Yanjuan; Lu, Jin; Liu, Hui; Hou, Ming; Cai, Zhen; Yang, Wei; Hao, Siguo; Jiang, Songfu; Jing, Hongmei; Liu, Jing; Du, Xin; Fu, Rong; Mei, Heng; Zhu, Zunmin; Yang, Yanli; Liu, Hong; Meng, Xingxing; Rajakumaraswamy, Nishanthan; Yuan, Daijing; Wang, Huamao; Li, Zonghai

Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study

tazemetostat(一种 EZH2 抑制剂)治疗中国复发/难治性滤泡性淋巴瘤患者的疗效和安全性:一项多中心、单臂 II 期研究

Cao, Junning; Chen, Guangliang; Qiu, Lihua; Zhang, Liling; Jiang, Ming; Cheng, Ying; Zhang, Qiaohua; Liu, Lihong; Li, Ping; Shuang, Yuerong; Wang, Huaqing; Xue, Hongwei; Wu, Huijing; Zheng, Meifang; Zhou, Keshu; Li, Zhiming; Jing, Hongmei; Yang, Wei; Zhu, Zunmin; Li, Wenyu; Wangwu, Jiaxuan; Huang, Heyu; Jia, Qiantao; Chen, Dongmei; Fan, Songhua; Shi, M Ming; Su, Weiguo

Polydatin upregulates ZDHHC19 to promote apoptosis of acute myeloid leukemia cells via mediating BID palmitoylation

白藜芦醇苷通过介导BID棕榈酰化作用上调ZDHHC19,从而促进急性髓系白血病细胞凋亡。

Zhang, Wenhui; Liu, Zhongwen; Pei, Xiaohang; Hao, Peiyuan; Jiang, Ling; Shi, Mingyue; Yuan, Xiaoli; Zhu, Zunmin

Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study

Epstein-Barr病毒DNA的动态变化可预测早期自然杀伤/T细胞淋巴瘤患者接受培门冬酶治疗后的预后:来自NHL-004多中心随机研究的长期随访和生物标志物分析

Zhong, Huijuan; Cheng, Shu; Xiong, Jie; Chen, Jiayi; Mu, Rongji; Yang, Haoxu; Yi, Hongmei; Song, Qi; Zhang, Hao; Hu, Yu; Cui, Guohui; Wei, Juying; Zhang, Xi; Xu, Bing; Qian, Wenbin; Huang, Xiaobing; Hou, Ming; Yan, Feng; Wang, Xin; Song, Yongping; Liu, Yuanhua; Ma, Xuejun; Hu, Jianda; Li, Fei; Wu, Chongyang; Chen, Junmin; Yu, Li; Bai, Ou; Xu, Jingyan; Zhu, Zunmin; Liu, Li; Zhou, Xin; Huang, Li; Tong, Yin; Niu, Ting; Wu, Depei; Jiang, Xufeng; Wang, Chaofu; Ouyang, Binshen; Cai, Gang; Li, Biao; Liu, Jia; Li, Zhifeng; Xiao, Rong; Wang, Luqun; Jiang, Yujie; Liu, Yanyan; Zheng, Xiaoyun; Xu, Pengpeng; Wang, Li; Chen, Saijuan; Zhao, Wei-Li

Long-term follow-up of patients with relapsed/refractory multiple myeloma after BCMA CAR-T-cell therapy

BCMA CAR-T细胞疗法治疗后复发/难治性多发性骨髓瘤患者的长期随访

Hao, Yuanyuan; Wang, Zhen; Zhang, Lei; Bai, Yanliang; Yuan, Xiaoli; Yang, Jing; Jiang, Li; Niu, Junwei; Cheng, Wei; Li, Wei; Huang, Zhoufeng; Chen, Yuqing; Sun, Kai; Zhu, Zunmin

Ferroptosis-related gene analysis revealing novel biomarkers and therapeutic targets in diffuse large B-cell lymphoma

铁死亡相关基因分析揭示弥漫性大B细胞淋巴瘤的新型生物标志物和治疗靶点

Liu, Lushe; Guo, Liqun; Zhang, Huiyang; Yu, Runhong; Hao, Yuanyuan; Dong, Xiaoyan; Dou, Rui; Zhu, Zunmin; Cheng, Linna

HPCAL1 as a novel prognostic biomarker in acute myeloid leukemia and its correlation with immune infiltrates

HPCAL1作为急性髓系白血病的新型预后生物标志物及其与免疫浸润的相关性

Cheng, Linna; Zhang, Huiyang; Shi, Mingyue; Zhu, Zunmin

Identification of the IFN-γ/IL-4 ratio as a prognostic biomarker and development of an immune-related prognostic model in diffuse large B-cell lymphoma

确定IFN-γ/IL-4比值作为弥漫性大B细胞淋巴瘤的预后生物标志物并建立免疫相关预后模型

Zhou, Pan; Zhou, Yunmeng; Yang, Liu; Liu, Chao; Zuo, Suqiong; Pei, Xiaohang; Ma, Rongjun; Chen, Yuqing; Zhu, Zunmin; Yuan, Xiaoli